News
-
-
COMMUNIQUÉ DE PRESSE
MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation
MIRA Pharmaceuticals to acquire SKNY Pharmaceuticals, enhancing MIRA pipeline with oral drug SKNY-1 for weight loss and nicotine cravings reversal. Shareholders approve merger with $30 million valuation -
-
COMMUNIQUÉ DE PRESSE
Nepra Foods Issues Letter from CEO
Nepra Foods CEO Billy Hogan expresses gratitude towards shareholders for support and shares company achievements. Revenue increased by 50.3% and net loss reduced by over 302% in fiscal year 2025. Focus on profitability and debt reduction highlighted -
COMMUNIQUÉ DE PRESSE
Progress in clinical development for Alzheimer´s and other indications: Galimedix Therapeutics successfully completes Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation modul
Galimedix successfully completes Phase 1 study with GAL-101, a small molecule targeting amyloid beta in Alzheimer's disease. Phase 2 trial planned -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW(R) Digital Cytology Microscope - Transforming Veterinary Imaging
Zomedica introduces TRUVIEW digital cytology microscope in veterinary care webinar showcasing rapid image capture and interpretation, enabling automated lab-quality blood film preparation
